Searched for
PFIZER EARNING
Weight-loss drug semaglutide set to get cheaper as generic wave builds in IndiaPrices for generic semaglutide, a popular weight-loss drug, are expected to fall by more than half in the coming months. This sharp decline...- US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
- Why US stock market Dow Jones, S&P 500 and Nasdaq are surging big today: Dow jumps 350 points, Nasdaq jumps 250 points as Intel hits all-time high driving the rallyUS stock market surges today: why Dow Jones, S&P 500, and Nasdaq are rallying sharply despite global tensions? The Dow Jones Industrial Ave...
- US stock market today: Why is Nasdaq crashing big today? Dow and S&P 500 slip as Nasdaq plunges over 300 points - Nvidia, AMD, Intel lead tech lossesUS stock market today: Nasdaq crashing big today as Dow Jones and S&P 500 also slip. The US stock market today shows a sharp shift. The Nas...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Why is PFE stock falling today despite beating Pfizer's earnings estimates? Key factors investors are watchingPFE stock today: Pfizer's stock dipped despite strong fourth-quarter earnings. Investors reacted to the company's modest 2026 outlook. Decl...
- Pfizer stock soars as earnings smash expectations, and company raises outlookPFE stock: Pfizer's stock surged following a report of stronger-than-expected earnings, driven by robust sales of COVID-19 products and key...
- Pfizer exceeds Q4 earnings estimates as covid product sales outperform expectationsStrong Covid product sales and cost-cutting initiatives drove Pfizer's $17.76 billion in revenue in Q4, exceeding Wall Street's projections...
- Pfizer Q2 Results: Profit tumbles 77% to $2.3 billion; co trims 2023 revenue outlookThese include US approval for a drug combination for prostate cancer and a needed recommendation on the Abrysvo vaccine from the US Centers...
- Pfizer forecasts 2021 earnings of $3 to $3.10 per shareWall Street analysts on average expect Pfizer to earn $3.07 per share, according to IBES data from Refinitiv.
- Pfizer Q2 net profit falls 14% to Rs 95.8 croreShares of Pfizer were trading at Rs 2,808 apiece in afternoon trade on BSE.
- Pfizer Q1 net profit up 61% to Rs 92 croreStandalone revenue from operations of the company stood at Rs 512.31 crore for the April-June quarter.
- Pfizer surges 5% as parent acquires Medivation in $14 bn dealThe US-based company said the acquisition would be immediately accretive to adjusted diluted EPS upon closing of the deal.
- Pfizer buying Hospira for about $15 billionThe deal is expected to add 10-12 cents per share to Pfizer's earnings in the first full-year after the deal closes.
- Pfizer posts Rs 63.14 cr profit for four months ended MarchDrug firm Pfizer today reported a net profit of Rs 63.14 crore for the four month period ended March 31, 2011.
- Pfizer 4Q profit beats views as revenue up 6 pcPfizer Inc.'s new CEO on Tuesday outlined plans to reduce the company's spending and work force and focus more sharply on promising drugs a...
- Pfizer 3Q profit down 70 pc due to chargesPfizer Inc said on Tuesday that revenue in the third quarter jumped 39 per cent, but hefty charges related to that $68 billion purchase dra...
- Pfizer profit dips 2 percent, sales fall much morePfizer Inc posted a 2 percent drop in first-quarter profit Tuesday, as cost-cutting by the world's largest drugmaker couldn't offset big dr...
- Pfizer Q3 profit doubles to $3.4bnPfizer on Thursday said third-quarter earnings doubled from the year-ago quarter when it took a big merger-related charge, helped by strong...
Load More
